Drug intelligence / Profile preview

Complivit

Development stage
Unknown
Lead developer
OTCPharm
Modality
Small Molecules
Administration
Oral
01

Overview

Complivit (Компливит) is a comprehensive multivitamin and mineral supplement developed and manufactured by the Russian pharmaceutical company OTCPharm. It is formulated as a dietary supplement to provide a balanced intake of essential nutrients, including vitamins A, C, E, and the B-complex (B1, B2, B3, B5, B6, B12, folic acid, and biotin), as well as key minerals such as iron, magnesium, zinc, copper, manganese, and selenium. The formulation also includes rutin and lipoic acid. Complivit is specifically designed to address the nutritional needs associated with the traditional Russian diet and utilizes a specialized granulation technology to ensure the stability and compatibility of its diverse components within a single tablet. It is primarily indicated for the prevention and treatment of vitamin and mineral deficiencies and for supporting overall metabolic health.

Brand names
ComplivitКомпливит
02

Targets

GPX4 (Glutathione peroxidase 4)RARA (Retinoic acid receptor alpha)PDH (Pyruvate dehydrogenase complex)PHD1 (Prolyl hydroxylase domain-containing protein 1)Misfolded SOD1DHFR (Dihydrofolate reductase)CA (Carbonic anhydrase)

Beyond the preview

Go deeper on Complivit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Complivit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call